Results - Announcements
Epigral Ltd share price softened by 3.25% to Rs 874.15 after the company's net profit witnessed a sharp fall of 34.75% to Rs 65.08 crore, while revenue from operations improved marginally 5.76% to Rs 745.99 crore in Q3FY26 over Q2FY26.
The market capitalization of Specialty Chemicals industry group stocks on BSE stood at Rs 5.61 lakh crore, heading higher 14.14%. It has inched up 0.63% over last one week and edged lower by 7.05% in last one month while the market capitalization of Epigral Ltd has slipped by 1.49% and 20.74% in the same period respectively.
Profit before tax (PBT) of Epigral Ltd stood at Rs 87.58 crore in Q3 FY26, jumping 25.74% year-on-year, and nosediving by 34.51% quarter-on-quarter. EBITDA came in at Rs 130 crore, declining 0.25% YoY and tumbling by 25.59% sequentially.
Total expenses rose by 14.95% to Rs 654.11 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 469.4 crore, inching up 9.12% YoY, while employee benefits expense was at Rs 33.7 crore, contracting 8.17% YoY.
For the TTM ended FY26, revenue from operations witnessed a strong growth of 32.19% to Rs 2550.13 crore, while net profit surged by 82.62% to Rs 357.69 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 48263% to Rs 695.51 crore, and PBT jumped 86.10% to Rs 541.09 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 440.56 crore in FY26, as against Rs 397.64 crore in FY25.
Epigral Ltd nosedived by 48.19% in last one year, underperforming the benchmark BSE Sensex which has declined by 11.78% during the same period.